1. 1. Mukherjee, S., & Mukherjee, U. (2009). A comprehensive review of immunosuppression used for liver transplantation. Journal of transplantation, 2009, 701464. https://doi.org/ 10.1155/2009/701464
2. Kokuhu, T., Fukushima, K., Ushigome, H., Yoshimura, N., & Sugioka, N. (2013). Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010. International journal of medical sciences, 10(12), 1665–1673. https://doi.org/10.7150/ijms.6727
3. Kang, J. S., & Lee, M. H. (2009). Overview of therapeutic drug monitoring. The Korean journal of internal medicine, 24(1), 1–10. https://doi.org/10.3904/kjim.2009.24.1.1
4. Ismael, I., Azeez, S. (2019). Immunosuppressive Drugs and KidneyPost-transplant Diabetes Mellitus. Hospital Practices and Research, 4(2), 50-56. doi: 10.15171/hpr.2019.09
5. Penfornis A, Kury-Paulin S. Immunosuppressive drug-induced diabetes. Diabetes Metab. 2006 Dec;32(5 Pt 2):539-46. doi: 10.1016/s1262-3636(06)72809-9. PMID: 17130815.
6. Bansal N. (2015). Prediabetes diagnosis and treatment: A review. World journal of diabetes, 6(2), 296–303. https://doi.org/10.4239/wjd.v6.i2.296
7. Mahmud, N., Klipa, D., & Ahsan, N. (2010). Antibody immunosuppressive therapy in solid-organ transplant: Part I. mAbs, 2(2), 148–156. https://doi.org/10.4161/mabs.2.2.11159
8. Kalluri, H. V., & Hardinger, K. L. (2012). Current state of renal transplant immunosuppression: Present and future. World journal of transplantation, 2(4), 51–68. https://doi.org/10.5500/wjt.v2.i4.51
9. Elsayed ASI, Bayomy MFF, Azab AE. Effect of acute and chronic treatment of Cyclosporine A on liver and kidney functions in rats. J Appl Pharm Sci. 2016;6(03):116–119.
10. Bardet V, Junior AP, Coste J, Lecoq-Lafon C, Chouzenoux S, Bernard D, Soubrane O, Lacombe C, Calmus Y, Conti F. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors. Liver Transpl. 2006 Nov;12(11):1649-54. doi: 10.1002/lt.20898. PMID: 17058250.
11. Pan, M. G., Xiong, Y., & Chen, F. (2013). NFAT gene family in inflammation and cancer. Current molecular medicine, 13(4), 543–554. https://doi.org/10.2174/1566524011313040007
12. Howell J, Sawhney R, Testro A, Skinner N, Gow P, Angus P, Ratnam D, Visvanathan K. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation. Liver Transpl. 2013 Oct;19(10):1099-107. doi: 10.1002/lt.23712. PMID: 23894100.
13. Russell RG, Graveley R, Coxon F, Skjodt H, Del Pozo E, Elford P, Mackenzie A. Cyclosporin A. Mode of action and effects on bone and joint tissues. Scand J Rheumatol Suppl. 1992;95:9-18. doi: 10.3109/03009749209101478. PMID: 1475634.
14. Elsayed ASI, Jbirea JM, Azab AE. Effect of acute and chronic cyclosporine a treatment on haematological data in male albino rats. J Appl Biotechnol Bioeng. 2018;5(6):350-357 DOI: 10.15406/jabb.2018.05.00164
15. Khalil, M., Khalil, M., Khan, T., & Tan, J. (2018). Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians. Journal of transplantation, 2018, 9429265. https://doi.org/10.1155/2018/9429265
16. Boes, K. M., & Durham, A. C. (2017). Bone Marrow, Blood Cells, and the Lymphoid/Lymphatic System. Pathologic Basis of Veterinary Disease, 724–804.e2. https://doi.org/10.1016/B978-0-323-35775-3.00013-8
17. Yoon, H. E., & Yang, C. W. (2009). Established and newly proposed mechanisms of chronic cyclosporine nephropathy. The Korean journal of internal medicine, 24(2), 81–92. https://doi.org/10.3904/kjim.2009.24.2.81
18. Pazhayattil, G. S., & Shirali, A. C. (2014). Drug-induced impairment of renal function. International journal of nephrology and renovascular disease, 7, 457–468. https://doi.org/10.2147/IJNRD.S39747
19. Kohan, D. E., Inscho, E. W., Wesson, D., & Pollock, D. M. (2011). Physiology of endothelin and the kidney. Comprehensive Physiology, 1(2), 883–919. https://doi.org/10.1002/cphy.c100039
20. Sereno, J., Rodrigues-Santos, P., Vala, H., Rocha-Pereira, P., Alves, R., Fernandes, J., Santos-Silva, A., Carvalho, E., Teixeira, F., & Reis, F. (2014). Transition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model. International journal of molecular sciences, 15(5), 8979–8997. https://doi.org/10.3390/ijms15058979
21. Takeda A, Uchida K, Haba T, Tominaga Y, Katayama A, Yoshida A, Oikawa T, Morozumi K. Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts. Clin Transplant. 2001;15 Suppl 5:22-9. doi: 10.1034/j.1399-0012.2001.0150s5022.x. PMID: 11791791.
22. Sandilands, E. A., Dhaun, N., Dear, J. W., & Webb, D. J. (2013). Measurement of renal function in patients with chronic kidney disease. British journal of clinical pharmacology, 76(4), 504–515. https://doi.org/10.1111/bcp.12198
23. Agnieszka Korolczuk, Kinga Caban, Magdalena Amarowicz, Grażyna Czechowska, Joanna Irla-Miduch, "Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity", BioMed Research International, vol. 2016, Article ID 5823271, 9 pages, 2016. https://doi.org/10.1155/2016/5823271
24. David, S., & Hamilton, J. P. (2010). Drug-induced Liver Injury. US gastroenterology & hepatology review, 6, 73–80.
25. Russmann, S., Kullak-Ublick, G. A., & Grattagliano, I. (2009). Current concepts of mechanisms in drug-induced hepatotoxicity. Current medicinal chemistry, 16(23), 3041–3053. https://doi.org/10.2174/092986709788803097
26. Maaike Kockx and Leonard Kritharides (October 3rd 2012). Cyclosporin A-Induced Hyperlipidemia, Lipoproteins - Role in Health and Diseases, Sasa Frank and Gerhard Kostner, IntechOpen, DOI: 10.5772/47866. Available from: https://www.intechopen.com/books/lipoproteins-role-in-health-and-diseases/ cyclosporin-a-induced-hyperlipidemia
27. Srinivas, T. R., & Meier-Kriesche, H. U. (2008). Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clinical journal of the American Society of Nephrology : CJASN, 3 Suppl 2(Suppl 2), S101–S116. https://doi.org/10.2215/CJN.03510807
28. Lee, J.M., Kronbichler, A., Shin, J.I. et al. Current understandings in treating children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 36, 747–761 (2021). https://doi.org/10.1007/s00467-020-04476-9.
|